Riboserv Incorp

Vertex Pharmaceuticals Incorporated is a global biotechnology company engaged in the discovery and development of breakthrough small molecule drugs for serious diseases. The company commercializes its products independently and in collaboration with major pharmaceutical companies. Vertex s product line includes drugs for viral diseases, inflammation, autoimmune diseases and cancer. Vertex is developing treatments for cancer, HIV and AIDS and pain through collaborations with some of the leading pharmaceutical companies. The company has collaborations with Cystic Fibrosis Foundation Therapeutics, GlaxoSmithKline, Kissei Pharmaceutical, Merck & Co., Mitsubishi Pharma Corporation and Novartis Pharma. Vertex co-promotes the HIV and AIDS protease inhibitor, Lexiva, with GlaxoSmithKline. Vertex Pharmaceuticals Incorporated is located in Cambridge, Mass.

Cell Signaling Technologies, based in Beverly, MA, is recognized globally for its extensive range of high-quality antibodies and related research products, serving the life sciences community for over 25 years. The company's product offerings include primary and secondary antibodies, ELISA kits, cellular assay kits, and an array of reagents and comprehensive solutions tailored for various applications including cancer research, immunology, and neuroscience. With a commitment to reliability and validation, Cell Signaling Technologies provides leading-edge solutions for research through robust assay platforms and continuous supply of essential products. Their dedication to environmental and social responsibility further underscores their role as a trusted partner in advancing scientific discovery. Generated from the website

Columbia Laboratories is an international pharmaceutical company whose mission is to provide new and better ways to meet the special health needs of people throughout the world. To achieve this objective, Columbia develops and has commercialized prescription and over-the-counter products that address the health care needs of women. This includes products used in infertility, hormonal deficiencies, vaginal odor and contraception. The company delivers these products primarily through its patented, proprietary bioadhesive delivery system that uses bioadhesion to administer medication to patients in a targeted fashion for 12 to 72 hours. This technology can deliver hormones and other difficult-to-deliver compounds. Columbia's public shares are traded on the NASDAQ under the symbol CBRX. Columbia Laboratories is headquartered in Livingston, N.J.